Banque de données en santé publique


Résultats de votre recherche

Votre recherche

mc.\*:("Antifungal agent")

Document Type [dt]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Année de publication [ap]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Langue [la]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Résultats 1 à 25 sur 99

  • Page / 4


Sélection :

  • et

Amphotericin B revisted : reassessment of toxicity.CLEMENTS (J.S.JR;) ; PEACOCK (J.E.JR.) ; Wake forest univ. Bowman gray school medicine. Sect infectious diseases. Winston Salem NC. USA. AMERICAN JOURNAL OF MEDICINE. 1990; 522N-527N, issn 0002-9343ARTICLE.

Voriconazole plasma monitoring.PASQUALOTTO (A.C.) ; SHAH (M.) ; WYNN (R.) et al. ARCHIVES OF DISEASE IN CHILDHOOD. 2008; 578-581, issn 0003-9888ARTICLE.

Prophylaxie des mycoses dans un service d'oncologie médicale : aspergilloses, candidoses. = Prophylaxis against Aspergillosis and Candidosis.RICHARD-LENOBLE (D.). BULLETIN DE LA SOCIETE FRANCAISE DE MYCOLOGIE MEDICALE. 1990; 145-150, issn 0373-8744ARTICLE.

The use of fluconazole in neonatal intensive care units.MANZONI (P.) ; MOSTERT (M.) ; JACQZ-AIGRAIN (E.) et al. ARCHIVES OF DISEASE IN CHILDHOOD. 2009; 983-987, issn 0003-9888ARTICLE.

Cohort Mortality Study of Workers Exposed to Perfluorooctanoic Acid.STEENLAND (Kyle) ; WOSKIE (Susan). AMERICAN JOURNAL OF EPIDEMIOLOGY. 2012; 909-917, issn 0002-9262ARTICLE.

Pharmacocinétique et pharmacodynamie des antifongiques en pédiatrie. = Pharmacokinetics and pharmacodynamics of antifungal drugs in children.JULLIEN (V.) ; DUPONT (Bertrand)(éd.). ARCHIVES DE PEDIATRIE. 2011; S42-, issn 0929-693XARTICLE.

Homophily and co-occurrence patterns shape randomized trials agendas : illustration in antifungal agents.RIZOS (Evangelos-C) ; SALANTI (Georgia) ; KONTOYIANNIS (Dimitrios-P) et al. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2011; 830-842, issn 0895-4356ARTICLE.

Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy : Results of a prospective cohort study.PATEL (Divya-A) ; GILLESPIE (Brenda) ; SOBEL (Jack-D) et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2004; 644-653, issn 0002-9378ARTICLE.

Study of condom integrity after brief exposure to over-the-counter vaginal preparations. ROSEN (A.D.) ; ROSEN (T.) ; College of Biomedical Science. Texas A & M University. Houston. TX. USA et al. SOUTHERN MEDICAL JOURNAL : (BIRMINGHAM). 1999; 305-307, issn 0038-4348ARTICLE.

Home intravenous anti-infective therapy (HIVAT) : do the benefits outweigh the risks ?WILLIAMS (D.N.). DRUG SAFETY. 1996; 1-7, issn 0114-5916ARTICLE.

Epidemiology and susceptibility to antifungal agents of fungi isolated from clinical specimens from patients hospitalized in the department of general and liver surgery of the Medical University of Warsaw.SWOBODA-KOPEC (E.) ; KAWECKI (D.) ; WROBLEWSKA (M.) et al. TRANSPLANTATION PROCEEDINGS. 2003; 2298-2303, issn 0041-1345ARTICLE, COMMUNICATION.

Pregnancy outcome after in utero exposure to itraconazole : A prospective cohort study. BAR-OZ (Benjamin) ; MORETTI (Myla-E) ; BISHAI (Raafat) et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2000; 617-620, issn 0002-9378ARTICLE.

Fungal infection in the intensive care unit. FLANAGAN (P.G.) ; BARNES (R.A.) ; Department of Medical Microbiology. University of Wales College of Medicine. Heath Park. Cardiff. GBR. THE JOURNAL OF HOSPITAL INFECTION. 1998; 163-177, issn 0195-6701ARTICLE.

Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.VAN DOORSLAER (E.K.A.) ; TORMANS (G.) ; GUPTA (A.K.) et al. DERMATOLOGY. 1996; 239-244, issn 1018-8665ARTICLE.

Cost Benefit and Cost Effectiveness of Antifungal Prophylaxis in Immunocompromised Patients Treated for Haematological Malignancies : Reviewing the Available Evidence.PECHLIVANOGLOU (Petros) ; DE VRIES (Robin) ; DAENEN (Simon-Mgj) et al. PHARMACOECONOMICS. 2011; 737-751, issn 1170-7690ARTICLE.

Economic evaluations of treatments for systemic fungal infections : A systematic review of the literature.DIXON (Simon) ; MCKEEN (Emma) ; TABBERER (Margaret) et al. PHARMACOECONOMICS. 2004; 421-433, issn 1170-7690ARTICLE.

A retrospective cost-effectiveness analysis of the treatment of onychomycosis in general practice. HUMPHREY (K.M.) ; CORK (M.J.) ; HAYCOX (A.). BRITISH JOURNAL OF DERMATOLOGY. 1998; 660-664, issn 0007-0963ARTICLE.

Management of infectious complication in cancer patients.NOSKIN (Gary-A)(éd.). CANCER TREATMENT AND RESEARCH. 1998; 308p., issn 0927-3042FASCICULE.

Onychomycose des orteils : aspects diagnostiques et stratégies thérapeutiques. = Toes onychomycosis : diagnosis viewpoint and therapeutic stategies.NARDI (L.). REVUE DE MEDECINE DU TRAVAIL. 1995; 83-86, issn 0300-0559ARTICLE.

Revision : Residuos de tratamientos veterinarios y salud publica. = Review : Residues of veterinary drugs and public health.MARTIN (R.) ; HERNANDEZ (P.E.) ; SANZ (B.) et al. REVISTA ESPANOLA DE CIENCIA Y TECNOLOGIA DE ALIMENTOS. 1992; 461-480ARTICLE.

Risk Factors for Fluconazole-Resistant Candida glabrata Bloodstream Infections.LEE (Ingi) ; FISHMAN (Neil-O) ; ZAOUTIS (Theoklis-E) et al. ARCHIVES OF INTERNAL MEDICINE. 2009; 379-383, issn 0003-9926ARTICLE.

Cost Effectiveness of Itraconazole in the Prophylaxis of Invasive Fungal Infections.DE VRIES (Robin) ; DAENEN (Simon) ; TOLLEY (Keith) et al. PHARMACOECONOMICS. 2008; 75-90, issn 1170-7690ARTICLE.

Analysis of urinary N - acetyl - S - (propionamide) - cysteine as a biomarker for the assessment of acrylamide exposure in smokers.HUANG (Chih-Chun-jean) ; LI (Chien-Ming) ; WU (Chia-Fang) et al. ENVIRONMENTAL RESEARCH. 2007; 346-351, issn 0013-9351ARTICLE.

Empirical anti-Candida therapy among selected patients in the intensive care unit : A cost-effectiveness analysis.GOLAN (Yoav) ; WOLF (Michael-P) ; PAUKER (Stephen-G) et al. ANNALS OF INTERNAL MEDICINE. 2005; 857-869, issn 0003-4819ARTICLE.

Achievements and goals of the EORTC Invasive Fungal Infections Group. DE PAUW (B.E.) ; HERBRECHT (R.) ; MEUNIER (F.) et al. EUROPEAN JOURNAL OF CANCER. SUPPLEMENT. 2002; S88-S93, issn 1359-6349ARTICLE.

  • Page / 4